scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-07-0151 |
P698 | PubMed publication ID | 17671137 |
P50 | author | Bernard H Bochner | Q42862211 |
Choichiro Ozu | Q125259967 | ||
Carlos Cordon-Cardo | Q11912384 | ||
P2093 | author name string | Makoto Ohori | |
Noriyuki Kasahara | |||
Silvia Menendez | |||
Eiji Kikuchi | |||
Christopher R Logg | |||
P433 | issue | 15 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4511-4518 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors | |
P478 | volume | 13 |
Q39661200 | Adenovirus–Retrovirus Hybrid Vectors Achieve Highly Enhanced Tumor Transduction and Antitumor Efficacy In Vivo |
Q33570888 | An orthotopic bladder cancer model for gene delivery studies |
Q35739482 | Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer |
Q37610904 | Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain |
Q37431500 | Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues. |
Q45863807 | Development of localized gene delivery using a dual-intensity ultrasound system in the bladder |
Q57801682 | Dual-vector prodrug activator gene therapy using retroviral replicating vectors |
Q39955895 | Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments. |
Q39066086 | Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus |
Q36980415 | Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy |
Q34580201 | Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector |
Q35175013 | Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma |
Q36602123 | Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types |
Q46655345 | Retroviral replicating vectors in cancer |
Q37642786 | Role and rationale of gene therapy and other novel therapies in the management of NMIBC. |
Q35588309 | Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model. |
Search more.